Robert DeBernardo, MD on Dual Immunotherapy for Advanced Cervical Cancer

(MedPage Today) -- A novel open-label, phase II trial recently published in the Journal of Clinical Oncology evaluated the safety and efficacy of balstilimab co-administered with zalifrelimab as second-line treatment for 155 patients with recurrent...